CFB 135 (Fenofibric Acid Delayed-Release 135 mg)
Pill with imprint CFB 135 is Blue & Yellow, Capsule-shape and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Aurobindo Pharma Limited.
Fenofibric acid is used in the treatment of hypertriglyceridemia; high cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for CFB 135
Fenofibric Acid Delayed-Release
- Imprint
- CFB 135
- Strength
- 135 mg
- Color
- Blue & Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Fibric acid derivatives
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Aurobindo Pharma Limited
- National Drug Code (NDC)
- 59651-0217
More about fenofibric acid
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 24 Reviews
- Drug class: fibric acid derivatives
- FDA Alerts (1)
Consumer resources
Other brands: Trilipix, Fibricor
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
